Temsirolimus package insert pdf in powerpoint

Treatment with the mtor inhibitor temsirolimus partially diminished survivin levels and this effect was augmented by the addition. Temsirolimus is supplied as a kit consisting of two vials. Apr 05, 2018 what are the possible side effects of temsirolimus torisel. Open the powerpoint slide where you want to insert the pdf.

The approval of temsirolimus for the treatment of metastatic rcc arises from the global study, an international, multicenter, openlabel, threearm phase iii trial that enrolled patients with. Studies with everolimus have also shown that prophylactic use of dexamethasone mouthwash may reduce the incidence of grade 2 or worse stomatitis when used regularly during the first 8 weeks of treatment. Torisel temsirolimus injection side effects, images. Torisel temsirolimus injection, 25 mgml, is a clear, colorless to light yellow, nonaqueous, ethanolic, sterile solution. Link to the pdf file there and select the pdf file, then ok. Torisel, when diluted, contains polysorbate 80, which is known to increase the rate of dehp extraction from pvc. Renal cell carcinoma a type of kidney cancer that is advanced. Inhibitors of cyp3a4 and pgp increase sirolimus concentrations. Cci779 is an ester derivative of rapamycin and has improved pharmaceutical properties. Also find the package insert, announcements, resources, and ways to connect with pfizer medical through a variety of channels. Temsirolimus is considered experimental and investigational for all other indications. Temsirolimus injection is used to treat advanced kidney cancer.

Excreted in feces 78% and urine 5% following iv dosing within 14 days. Torisel medication page for healthcare professionals to search for scientific information on pfizer medications. Torisel kit temsirolimus injection, for intravenous infusion only initial u. Temsirolimus binds to and inhibits the mammalian target of rapamycin mtor, resulting in decreased expression of mrnas necessary for cell cycle progression and arresting cells in the g1 phase of the cell cycle. Temsirolimus is used to treat cancer of the kidneys, also called renal. Torisel temsirolimus injection requires two dilutions prior to. Torisel is indicated for the treatment of advanced renal cell carcinoma. It is usually given by a doctor or nurse in a doctors office or infusion center. Clinical trials are research studies that involve people. Temsirolimus torisel medical clinical policy bulletins. Temsirolimus is used in the treatment of advanced renal cell. Torisel kit te msirolimus injection, for intr avenous infusion only. Temsirolimus is a powerful inhibitor of platelet activation and.

Temsirolimus in treating patients with metastatic neuroendocrine carcinoma the safety and scientific validity of this study is the responsibility of the study sponsor and. Hypersensitivityinfusion reactions, including flushing, chest pain, dyspnea, hypotension, apnea, loss of consciousness, hypersensitivity, and anaphylaxis. Torisel temsirolimus injection requires two dilutions prior to intravenous infusion. Highlights of prescribing information these highlights. Temsirolimus is the 2,2bis hydroxymethyl propionic acid ester of. Follow applicable special handling and disposal procedures 1. Temsirolimus is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Pfizer seeks to stymie sandoz, accords generic torisel. Mtt and propidium iodide pi were purchased from sigma aldrich.

Temsirolimus is a targeted therapy and is classified as a mtor inhibitor. Temsirolimus torisel for kidney cancer chemoexperts. Sirolimus or everolimus or temsirolimus and vorinostat in. Potential histologic and molecular predictors of response to. What are the possible side effects of temsirolimus torisel. Keywords clear cell carcinoma, temsirolimus, mtor, rapamycin, safety.

It is administered by intravenous infusion iv, with an anticipated dose regime for mcl of 175mg once weekly for three weeks, followed by 75mg once. Similar to other molecularly targeted agents, temsirolimus, an inhibitor of mammalian target of rapamycin, has shown promising activity in advanced renal cell. It blocks the effects of a protein called mtor that is often over active in cancer cells. In the insert object box, select create from file, and then enter the pdf file location. Prescribing information hycamtin topotecan hydrochloride for injection for intravenous use warning hycamtin topotecan hydrochloride for injection should be administered under the supervision of a physician experienced in the use of cancer chemotherapeutic agents. Highlights of prescribing information these highlights do not include all the information needed to use torisel safely and effectively. This should be considered during the preparation and administration of torisel, including storage time elapsed when in direct contact with pvc following constitution. Go to insert and select object to open the insert object dialog box. The clinical trials on this list are studying temsirolimus.

Phase iii study to evaluate temsirolimus compared with investigators choice therapy for the treatment of relapsed or refractory mantle cell lymphoma. Renal cell carcinoma treatment regimens cancer therapy. Temsirolimus is used to treat cancer of the kidneys, also called renal cell carcinoma. Temsirolimus is also being studied in the treatment of other types of cancer. Food and drug administration fda in late may 2007, and was also approved by the european medicines agency emea on november 2007. Open your powerpoint presentation on the page you want to insert the pdf within. A phase 2 study with a daily regimen of the oral mtor. This makes the pdf file part of the presentation file.

Get emergency medical help if you have signs of an allergic reaction hives, difficult breathing, swelling in your face or throat or a severe skin reaction fever, sore throat, burning eyes, skin pain, red or purple skin rash with blistering and peeling. Temsirolimus binds to an intracellular protein fkbp. Temsirolimus, interferon alfa, or both for advanced renalcell carcinoma. Temsirolimus side effects, dosage, interactions drugs. Temsirolimus torisel is an intravenous chemotherapeutic agent in the. Open the folder that contains the pdf file you want, choose the pdf file, and select ok.

Torisel temsirolimus dosing, indications, interactions. Temsirolimus also stops the cancer from making blood vessels, which the cells need to be able to grow. In some cases, health care professionals may use the trade name torisel when referring to the generic drug name temsirolimus. To report an adverse event, please call 18004381985. Temsirolimus is an inhibitor of mtor mammalian target of rapamycin. All trials on the list are supported by nci ncis basic information about clinical. Inhibition of mtor activity resulted in a g1 growth arrest in treated tumor cells. Sirolimus is extensively metabolized in the intestinal wall and liver and undergoes countertransport from enterocytes of the small intestine into the gut lumen.

If torisel must be given to patients with mild hepatic impairment, reduce the dose of torisel to 15 mgweek. Due to the intentional overfill in the torisel injection vial, the drug concentration of the resulting solution. Torisel is contraindicated in patients with bilirubin 1. Temsirolimus sensitive stimulation of platelet activity, apoptosis. Any relevant documentation to support medical necessity package insert, chart or lab notes, letter of medical necessity consult with the payer regarding specific claim and documentation. Temsirolimus temsirolimus injection, 25 mgml, is a clear, colorless to light yellow, nonaqueous, ethanolic, sterile solution. Temsirolimus comes as a solution liquid to be given by infusion slow injection into a vein over 30 to 60 minutes. Temsirolimus is designed to slow the growth of kidney cancer cells by inhibiting several mechanisms that the cell uses to grow and survive.

Authorization of 3 months may be granted for members prescribed torisel as primary therapy for disease not suitable for primary surgery in members with suspected or gross cervical. Get emergency medical help if you have signs of an allergic reaction hives, difficult breathing, swelling in your. Temsirolimus torisel temsirolimus torisel is a chemotherapy regimen for renal cell carcinoma kidney cancer. Each kit is supplied in a single carton containing one singleuse vial of 25 mgml of temsirolimus and one diluent vial which includes a deliverable volume of 1. Temsirolimus cancer information cancer research uk.

Temsirolimus torisel for mantle cell lymphoma relapsed. The nccn recommends cancer patient participation in clinical trials as the gold standard for treatment. Torisel temsirolimus injection worldwide fact sheet. Temsirolimus torisel, cci779 is a mammalian target of rapamycin mtor signal transduction inhibitor, which blocks a number of signal transduction pathways involved in cell cycle regulation. Torisel temsirolimus injection should be diluted only with the supplied diluent for torisel. Torisel temsirolimus is indicated for the treatment of advanced renal cell carcinoma. Cci779 is a potent inhibitor of mtor with ic50 values of 0. Torisel should be used with caution in persons with known hypersensitivity to temsirolimus or its metabolites including sirolimus, polysorbate 80, or to any other component including the excipients of torisel. Sodium bicarbonate solutions or oral antifungal agents do not appear to be effective for. In some cases, health care professionals may use the trade name torisel when referring to the generic drug.

Temsirolimus is the generic name for the trade name chemotherapy drug torisel. Sirolimus is extensively metabolized in the intestinal wall and liver and undergoes countertransport from enterocytes of the small. Clinical trials using temsirolimus national cancer institute. It is usually given once a week over 30 to 60 minutes or as directed by your. Any relevant documentation to support medical necessity package insert, chart or lab notes, letter of medical necessity consult with the payer regarding specific claim and documentation requirements. Hospital outpatient medicare only hospital outpatient facilities may use ccodes to report drugs and procedures provided to medicare patients. Highlights of prescribing information monitor for symptoms.

Mar 16, 2010 sirolimus or everolimus or temsirolimus and vorinostat in advanced cancer the safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Sirolimus or everolimus or temsirolimus and vorinostat in advanced cancer the safety and scientific validity of this study is the responsibility of the study sponsor and. Please see full prescribing information for torisel temsirolimus. Definition from the nci drug dictionary detailed scientific definition and other names for this drug. The torisel temsirolimus vial contains an overfill of 0. Temsirolimus is a substrate of the efflux transporter pglycoprotein pgp in vitro. It interferes with the growth of cancer cells, which are eventually destroyed by the body.

Targeting survivin inhibits renal cell carcinoma progression and. Temsirolimus binds to an intracellular protein fkbp12, and the proteindrug complex inhibits the activity of mtor. Renal cell carcinoma treatment regimens cancer therapy advisor. Temsirolimus infusion should be interrupted in all patients with severe infusion reactions and appropriate medical therapy administered. Nov 09, 2018 temsirolimus is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Torisel temsirolimus torisel reimbursement support program. Temsirolimus is the 2,2bis hydroxymethyl propionic acid ester of sirolimus, a macrocyclic lactone produced by streptomyces hygroscopicus. Temsirolimus is a type of targeted cancer drug treatment called an mtor inhibitor. Insert pdf file content into a powerpoint presentation powerpoint. Temsirolimus inhibits mammalian target of rapamycin mtor kinase signaling by binding to the intracellular protein fkbp12. Etopophos etoposide phosphate for injection is an antineoplastic agent which is available for intravenous infusion as a sterile lyophile in singledose vials containing etoposide phosphate. Highlights of prescribing information monitor for symptoms or.

In powerpoint, select the slide that you want to add the file to, and then select insert object. Food and drug administration fda in may 2007 for the treatment of. Insert pdf content into your presentation either as a picture that shows on your slide, or as a document that you can open during your slide show. Temsirolimus binds to and inhibits the mammalian target of rapamycin mtor, resulting in decreased expression of mrnas necessary for cell. Insert pdf file content into a powerpoint presentation. Mar 23, 2010 temsirolimus is a prodrug of sirolimus, which is marketed as rapamune wyeth pharmaceuticals, inc. Torisel temsirolimus torisel 25 mg concentrate for injection. This medication is given by injection into a vein by a health care professional. Patients enrolled in the study had advanced disease and three or more factors indicating a. Torisel temsirolimus injection side effects, images, uses. The clinical benefit of temsirolimus for poorrisk, advanced rcc patients was demonstrated in a phase iii study comparing temsirolimus with interferon alpha ifnalpha or combined temsirolimus plus ifnalpha as firstline treatment of advanced rcc, showed that treatment with temsirolimus alone significantly increased median overall survival in. Jan 22, 2020 temsirolimus metabolized by hydrolysis to sirolimus, the principal active metabolite. Temsirolimus treatment for 2 weeks also delays the growth of rapamycinresistant u251.

Temsirolimus torisel is an inhibitor of mammalian target of rapamycin mtor. Torisel temsirolimus pfizer medical information us. Because many drugs are excreted in human milk, and because of the potential for adverse reactions in nursing infants from temsirolimus, a decision should be made whether to. A kit has been used for the detection of activated caspase 3.

Pfizer seeks to stymie sandoz, accords generic torisel law360. Temsirolimus treatment for 2 weeks also delays the growth of rapamycinresistant u251 xenografts by 148%. Oct 25, 2019 renal cell carcinoma treatment regimens. The concentratediluent mixture is stable below 25c for up to 24 hours.

Temsirolimus codenamed cci779 is an intravenous drug for the treatment of renal cell carcinoma rcc, developed by wyeth pharmaceuticals and approved by the u. Download figure open in new tab download powerpoint. Torisel temsirolimus how suppliedstorage and handling. Temsirolimus binds to an intracellular protein fkbp12, and the proteindrug complex inhibits the activity of mtor that controls cell division. Listing a study does not mean it has been evaluated by the u.

1482 6 759 1428 1320 1611 526 1518 94 957 1095 1293 35 872 146 471 647 1363 590 1395 1440 102 910 85 511 212 1247 140 562 634 139 509 707 767 923 69 796 976 1431 179 262 562 201 149 1407 320 1115 1123 331